Sensitivity of thrombin and plasmin to heparin and antithrombin III. 1985

P I Bauer, and Z Breuer, and R Machovich, and K G Büki, and I Horváth

Thrombin and plasmin are inactivated by antithrombin III at different rates. Heparin, at a catalytic amount, increases primarily the inactivation rate of thrombin. The two proteinases compete for heparin, i.e. heparin is preferably attached by thrombin. Furthermore, fibrinogen as well as fibrin protect plasmin against inactivation by antithrombin III. However, at high concentration of heparin, plasmin inactivation by antithrombin III is accelerated even in the presence of fibrinogen or fibrin.

UI MeSH Term Description Entries
D007700 Kinetics The rate dynamics in chemical or physical systems.
D011485 Protein Binding The process in which substances, either endogenous or exogenous, bind to proteins, peptides, enzymes, protein precursors, or allied compounds. Specific protein-binding measures are often used as assays in diagnostic assessments. Plasma Protein Binding Capacity,Binding, Protein
D005341 Fibrinolysin A product of the lysis of plasminogen (profibrinolysin) by PLASMINOGEN activators. It is composed of two polypeptide chains, light (B) and heavy (A), with a molecular weight of 75,000. It is the major proteolytic enzyme involved in blood clot retraction or the lysis of fibrin and quickly inactivated by antiplasmins. Plasmin,Fibrogammin,Glu-Plasmin,Protease F,Thrombolysin,Glu Plasmin
D006493 Heparin A highly acidic mucopolysaccharide formed of equal parts of sulfated D-glucosamine and D-glucuronic acid with sulfaminic bridges. The molecular weight ranges from six to twenty thousand. Heparin occurs in and is obtained from liver, lung, mast cells, etc., of vertebrates. Its function is unknown, but it is used to prevent blood clotting in vivo and vitro, in the form of many different salts. Heparinic Acid,alpha-Heparin,Heparin Sodium,Liquaemin,Sodium Heparin,Unfractionated Heparin,Heparin, Sodium,Heparin, Unfractionated,alpha Heparin
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000991 Antithrombins Endogenous factors and drugs that directly inhibit the action of THROMBIN, usually by blocking its enzymatic activity. They are distinguished from INDIRECT THROMBIN INHIBITORS, such as HEPARIN, which act by enhancing the inhibitory effects of antithrombins. Antithrombin,Direct Antithrombin,Direct Antithrombins,Direct Thrombin Inhibitor,Direct Thrombin Inhibitors,Antithrombin, Direct,Antithrombins, Direct,Inhibitor, Direct Thrombin,Thrombin Inhibitor, Direct,Thrombin Inhibitors, Direct
D013917 Thrombin An enzyme formed from PROTHROMBIN that converts FIBRINOGEN to FIBRIN. Thrombase,Thrombin JMI,Thrombin-JMI,Thrombinar,Thrombostat,alpha-Thrombin,beta,gamma-Thrombin,beta-Thrombin,gamma-Thrombin,JMI, Thrombin

Related Publications

P I Bauer, and Z Breuer, and R Machovich, and K G Büki, and I Horváth
August 1989, Biochimica et biophysica acta,
P I Bauer, and Z Breuer, and R Machovich, and K G Büki, and I Horváth
March 1986, The Journal of biological chemistry,
P I Bauer, and Z Breuer, and R Machovich, and K G Büki, and I Horváth
May 1977, Thrombosis research,
P I Bauer, and Z Breuer, and R Machovich, and K G Büki, and I Horváth
December 1977, Thrombosis research,
P I Bauer, and Z Breuer, and R Machovich, and K G Büki, and I Horváth
December 1982, The Journal of biological chemistry,
P I Bauer, and Z Breuer, and R Machovich, and K G Büki, and I Horváth
August 1976, Thrombosis research,
P I Bauer, and Z Breuer, and R Machovich, and K G Büki, and I Horváth
January 1977, Federation proceedings,
P I Bauer, and Z Breuer, and R Machovich, and K G Büki, and I Horváth
July 1979, Prostaglandins,
P I Bauer, and Z Breuer, and R Machovich, and K G Büki, and I Horváth
January 1980, Thrombosis research,
P I Bauer, and Z Breuer, and R Machovich, and K G Büki, and I Horváth
January 1979, Thrombosis research,
Copied contents to your clipboard!